These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17893988)

  • 21. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus.
    Yang J; Li Q; Yang X; Li M
    Lupus; 2016 Apr; 25(5):513-9. PubMed ID: 26678441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of pregnancies complicated by systemic lupus erythematosus (SLE).
    Phadungkiatwattana P; Sirivatanapa P; Tongsong T
    J Med Assoc Thai; 2007 Oct; 90(10):1981-5. PubMed ID: 18041412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pregnancy and antiphospholipid antibodies in systemic lupus erithematosus patients: an outcome evaluation].
    Cordeiro A; Lermann R; Ambrósio P; Nogueira I; Serrano F
    Acta Reumatol Port; 2009; 34(3):486-91. PubMed ID: 19820672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Buskila D; Lorber M; Neumann L; Flusser D; Shoenfeld Y
    J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.
    Balevic SJ; Cohen-Wolkowiez M; Eudy AM; Green TP; Schanberg LE; Clowse MEB
    J Rheumatol; 2019 Jan; 46(1):57-63. PubMed ID: 30275257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma homovanillic acid and prolactin in systemic lupus erythematosus.
    Ferreira C; Paes M; Gouveia A; Ferreira E; Pádua F; Fiúza T
    Lupus; 1998; 7(6):392-7. PubMed ID: 9736322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 study.
    Larosa M; Le Guern V; Guettrot-Imbert G; Morel N; Abisror N; Morati-Hafsaoui C; Orquevaux P; Diot E; Doria A; Sarrot-Reynauld F; Limal N; Queyrel V; Souchaud-Debouverie O; Sailler L; Le Besnerais M; Goulenok T; Molto A; Pannier-Metzger E; Sentilhes L; Mouthon L; Lazaro E; Costedoat-Chalumeau N;
    Rheumatology (Oxford); 2022 Aug; 61(9):3657-3666. PubMed ID: 35015828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus.
    Karimifar M; Tahmasebi A; Bonakdar ZS; Purajam S
    Rheumatol Int; 2013 Feb; 33(2):511-6. PubMed ID: 22065074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.
    Paraiba DB; Soares CR; Bartolini P; Arthuso FS; Borba EF; Bonfa E; Bronstein MD
    Clin Exp Rheumatol; 2010; 28(6):866-72. PubMed ID: 21205462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinico-immunological aspects of antiphospholipid syndrome].
    Reshetniak TM; Alekberova ZS; Aleksandrova EN
    Vestn Ross Akad Med Nauk; 2003; (7):31-4. PubMed ID: 12934468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity.
    Gutiérrez MA; Molina JF; Jara LJ; Cuéllar ML; García C; Gutiérrez-Ureña S; Gharavi A; Espinoza LR
    Lupus; 1995 Oct; 4(5):348-52. PubMed ID: 8563728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum inhibin A levels in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome.
    Maymon R; Sehmi IK; Herman A; Jones RG; Sherman D; Cuckle H
    Prenat Diagn; 2000 Jan; 20(1):12-6. PubMed ID: 10701844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of neutrophile/lymphocyte ratio and serum chemerin to predict maternal-fetal complications in pregnant systemic lupus erythematosus patients.
    Medina G; González-Cortés FR; Sánchez-González A; Vázquez-Rodríguez JG; Ordoñez-González I; Jiménez-Arellano MP; García-Collinot G; Morales-Montalvo SI; Florez-Durante OI; Cruz-Domínguez MP; Colorado-Cruz MF; Zurita-Muñoz MA; Cruz-Arteaga G; Sánchez-Enriquez C; Jara LJ; Saavedra MÁ
    Lupus; 2023 Oct; 32(12):1409-1417. PubMed ID: 37840528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The incidence of the antiphospholipid syndrome in the clinical and biological manifestations of systemic lupus erythematosus].
    Sánchez Rodríguez A; Martín Oterino JA; Fidalgo Fernández MA; Araoz Sánchez P; Alonso García P; Fernández Navarro P; Chimpén Ruiz V; Portugal Alvarez J
    Rev Clin Esp; 1997 Oct; 197(10):669-74. PubMed ID: 9424663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.